Please enable JavaScript to continue using this application.

Compare tickers

Valuation, margins, and growth side by side.

Compare $MRK vs $RPRX | Chartloom

Compare

$MRK vs $RPRX

Merck & Co Inc · Royalty Pharma PLC

MRK

Merck & Co Inc

RPRX

Royalty Pharma PLC

Compare $MRK vs $RPRX

Comparing Merck & Co Inc and Royalty Pharma PLC

MRKMerck & Co Inc

RPRXRoyalty Pharma PLC

MRKMerck & Co Inc

Market cap

$350.67B

P/E (TTM)

110.52x

Forward P/E (NTM)

16.48x

Forward P/S (NTM)

5.10x

Rev growth (TTM)

4.6%

YTD performance

33.4%

52W performance

65.1%

FCF yield

4.6%

RPRXRoyalty Pharma PLC

Market cap

$32.57B

P/E (TTM)

38.65x

Forward P/E (NTM)

11.88x

Forward P/S (NTM)

9.72x

Rev growth (TTM)

10.0%

YTD performance

45.6%

52W performance

57.1%

FCF yield

1.8%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

MRK

RPRX

Detailed metrics comparison

MRK

Merck & Co Inc

RPRX

Royalty Pharma PLC

Market Cap

MRK$350.67B

RPRX$32.57B

Enterprise Value

MRK$397.72B

RPRX$40.72B

Price

MRK$141.98

RPRX$56.57

P/E Ratio

MRK110.52x

RPRX38.65x

P/S Ratio

MRK5.27x

RPRX12.84x

EV/Sales

MRK5.97x

RPRX16.06x

EV/EBITDA

MRK22.57x

RPRX25.19x

P/B Ratio

MRK8.57x

RPRX4.79x

P/FCF Ratio

MRK21.83x

RPRX56.41x

EV/FCF

MRK24.76x

RPRX70.52x

PEG Ratio

MRK17.81x

RPRX3.89x

Forward P/E (NTM)

MRK16.48x

RPRX11.88x

Forward P/S (NTM)

MRK5.10x

RPRX9.72x

Revenue (TTM)

MRK$66.57B

RPRX$2.54B

Revenue Growth (YoY)

MRK4.6%

RPRX10.0%

Forward Rev Growth

MRK4.7%

RPRX5.2%

Gross Margin (TTM)

MRK77.3%

RPRX0.0%

Operating Margin (TTM)

MRK9.6%

RPRX59.6%

EBITDA Margin (TTM)

MRK26.3%

RPRX62.3%

Net Margin (TTM)

MRK4.8%

RPRX32.1%

FCF Margin (TTM)

MRK24.1%

RPRX22.8%

Net Income (TTM)

MRK$3.17B

RPRX$815M

FCF (TTM)

MRK$16.06B

RPRX$578M

EPS (TTM)

MRK$1.28

RPRX$1.46

ROE (TTM)

MRK6.6%

RPRX12.3%

ROA (TTM)

MRK2.4%

RPRX4.2%

ROIC (TTM)

MRK3.3%

RPRX5.2%

Cash

MRK$6.85B

RPRX$812M

Debt

MRK$53.91B

RPRX$8.96B

Net Cash/Debt

MRK$-47.06B

RPRX$-8.15B

Current Ratio (TTM)

MRK1.32x

RPRX2.80x

Quick Ratio (TTM)

MRK1.10x

RPRX2.80x

Debt/Equity (TTM)

MRK1.29x

RPRX1.31x

Debt/Assets (TTM)

MRK0.0%

RPRX0.0%

Interest Coverage (TTM)

MRKN/A

RPRXN/A

Net Debt/EBITDA (TTM)

MRK0.00x

RPRX0.00x

Beta

MRK0.12

RPRX0.39

52W Performance

MRK65.1%

RPRX57.1%

YTD Performance

MRK33.4%

RPRX45.6%

% from 52W High

MRK-9.5%

RPRX-12.1%

% from 52W Low

MRK73.1%

RPRX60.6%

Asset Turnover (TTM)

MRK0.51x

RPRX0.13x

FCF Yield (TTM)

MRK4.6%

RPRX1.8%

Earnings Yield (TTM)

MRK0.9%

RPRX2.5%

Dividend Yield (TTM)

MRK2.3%

RPRX1.2%

Rule of 40

MRK28.8

RPRX32.8

EV/GP/RG

MRK2.37

RPRXN/A

Ticker research

View MRK research View RPRX research

Metric	MRK Merck & Co Inc	RPRX Royalty Pharma PLC
Market & Valuation
Market Cap	$350.67B	$32.57B
Enterprise Value	$397.72B	$40.72B
Price	$141.98	$56.57
P/E Ratio	110.52x	38.65x
P/S Ratio	5.27x	12.84x
EV/Sales	5.97x	16.06x
EV/EBITDA	22.57x	25.19x
P/B Ratio	8.57x	4.79x
P/FCF Ratio	21.83x	56.41x
EV/FCF	24.76x	70.52x
PEG Ratio	17.81x	3.89x
Forward P/E (NTM)	16.48x	11.88x
Forward P/S (NTM)	5.10x	9.72x
Revenue & Growth
Revenue (TTM)	$66.57B	$2.54B
Revenue Growth (YoY)	4.6%	10.0%
Forward Rev Growth	4.7%	5.2%
Profitability
Gross Margin (TTM)	77.3%	0.0%
Operating Margin (TTM)	9.6%	59.6%
EBITDA Margin (TTM)	26.3%	62.3%
Net Margin (TTM)	4.8%	32.1%
FCF Margin (TTM)	24.1%	22.8%
Net Income (TTM)	$3.17B	$815M
FCF (TTM)	$16.06B	$578M
EPS (TTM)	$1.28	$1.46
ROE (TTM)	6.6%	12.3%
ROA (TTM)	2.4%	4.2%
ROIC (TTM)	3.3%	5.2%
Financial Health
Cash	$6.85B	$812M
Debt	$53.91B	$8.96B
Net Cash/Debt	$-47.06B	$-8.15B
Current Ratio (TTM)	1.32x	2.80x
Quick Ratio (TTM)	1.10x	2.80x
Debt/Equity (TTM)	1.29x	1.31x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.12	0.39
52W Performance	65.1%	57.1%
YTD Performance	33.4%	45.6%
% from 52W High	-9.5%	-12.1%
% from 52W Low	73.1%	60.6%
Efficiency & Yields
Asset Turnover (TTM)	0.51x	0.13x
FCF Yield (TTM)	4.6%	1.8%
Earnings Yield (TTM)	0.9%	2.5%
Dividend Yield (TTM)	2.3%	1.2%
Other
Rule of 40	28.8	32.8
EV/GP/RG	2.37	N/A
Ticker research	View MRK research	View RPRX research

Valuation

P/E Ratio

RPRX

38.65x

MRK

110.52x

P/S Ratio

MRK

5.27x

RPRX

12.84x

EV/FCF

MRK

24.76x

RPRX

70.52x

Growth & revenue

Revenue Growth TTM

RPRX

10.0%

MRK

4.6%

Forward Revenue Growth

RPRX

5.2%

MRK

4.7%

Profitability & performance

Gross Margin

MRK

77.3%

RPRX

0.0%

ROE

RPRX

12.3%

MRK

6.6%

FCF Yield %

MRK

4.6%

RPRX

1.8%

52-Week Performance

MRK

65.1%

RPRX

57.1%

Detailed metrics comparison

MRK

Merck & Co Inc

RPRX

Royalty Pharma PLC

Market Cap

MRK$350.67B

RPRX$32.57B

Enterprise Value

MRK$397.72B

RPRX$40.72B

Price

MRK$141.98

RPRX$56.57

P/E Ratio

MRK110.52x

RPRX38.65x

P/S Ratio

MRK5.27x

RPRX12.84x

EV/Sales

MRK5.97x

RPRX16.06x

EV/EBITDA

MRK22.57x

RPRX25.19x

P/B Ratio

MRK8.57x

RPRX4.79x

P/FCF Ratio

MRK21.83x

RPRX56.41x

EV/FCF

MRK24.76x

RPRX70.52x

PEG Ratio

MRK17.81x

RPRX3.89x

Forward P/E (NTM)

MRK16.48x

RPRX11.88x

Forward P/S (NTM)

MRK5.10x

RPRX9.72x

Revenue (TTM)

MRK$66.57B

RPRX$2.54B

Revenue Growth (YoY)

MRK4.6%

RPRX10.0%

Forward Rev Growth

MRK4.7%

RPRX5.2%

Gross Margin (TTM)

MRK77.3%

RPRX0.0%

Operating Margin (TTM)

MRK9.6%

RPRX59.6%

EBITDA Margin (TTM)

MRK26.3%

RPRX62.3%

Net Margin (TTM)

MRK4.8%

RPRX32.1%

FCF Margin (TTM)

MRK24.1%

RPRX22.8%

Net Income (TTM)

MRK$3.17B

RPRX$815M

FCF (TTM)

MRK$16.06B

RPRX$578M

EPS (TTM)

MRK$1.28

RPRX$1.46

ROE (TTM)

MRK6.6%

RPRX12.3%

ROA (TTM)

MRK2.4%

RPRX4.2%

ROIC (TTM)

MRK3.3%

RPRX5.2%

Cash

MRK$6.85B

RPRX$812M

Debt

MRK$53.91B

RPRX$8.96B

Net Cash/Debt

MRK$-47.06B

RPRX$-8.15B

Current Ratio (TTM)

MRK1.32x

RPRX2.80x

Quick Ratio (TTM)

MRK1.10x

RPRX2.80x

Debt/Equity (TTM)

MRK1.29x

RPRX1.31x

Debt/Assets (TTM)

MRK0.0%

RPRX0.0%

Interest Coverage (TTM)

MRKN/A

RPRXN/A

Net Debt/EBITDA (TTM)

MRK0.00x

RPRX0.00x

Beta

MRK0.12

RPRX0.39

52W Performance

MRK65.1%

RPRX57.1%

YTD Performance

MRK33.4%

RPRX45.6%

% from 52W High

MRK-9.5%

RPRX-12.1%

% from 52W Low

MRK73.1%

RPRX60.6%

Asset Turnover (TTM)

MRK0.51x

RPRX0.13x

FCF Yield (TTM)

MRK4.6%

RPRX1.8%

Earnings Yield (TTM)

MRK0.9%

RPRX2.5%

Dividend Yield (TTM)

MRK2.3%

RPRX1.2%

Rule of 40

MRK28.8

RPRX32.8

EV/GP/RG

MRK2.37

RPRXN/A

Ticker research

View MRK research View RPRX research

Metric	MRK Merck & Co Inc	RPRX Royalty Pharma PLC
Market & Valuation
Market Cap	$350.67B	$32.57B
Enterprise Value	$397.72B	$40.72B
Price	$141.98	$56.57
P/E Ratio	110.52x	38.65x
P/S Ratio	5.27x	12.84x
EV/Sales	5.97x	16.06x
EV/EBITDA	22.57x	25.19x
P/B Ratio	8.57x	4.79x
P/FCF Ratio	21.83x	56.41x
EV/FCF	24.76x	70.52x
PEG Ratio	17.81x	3.89x
Forward P/E (NTM)	16.48x	11.88x
Forward P/S (NTM)	5.10x	9.72x
Revenue & Growth
Revenue (TTM)	$66.57B	$2.54B
Revenue Growth (YoY)	4.6%	10.0%
Forward Rev Growth	4.7%	5.2%
Profitability
Gross Margin (TTM)	77.3%	0.0%
Operating Margin (TTM)	9.6%	59.6%
EBITDA Margin (TTM)	26.3%	62.3%
Net Margin (TTM)	4.8%	32.1%
FCF Margin (TTM)	24.1%	22.8%
Net Income (TTM)	$3.17B	$815M
FCF (TTM)	$16.06B	$578M
EPS (TTM)	$1.28	$1.46
ROE (TTM)	6.6%	12.3%
ROA (TTM)	2.4%	4.2%
ROIC (TTM)	3.3%	5.2%
Financial Health
Cash	$6.85B	$812M
Debt	$53.91B	$8.96B
Net Cash/Debt	$-47.06B	$-8.15B
Current Ratio (TTM)	1.32x	2.80x
Quick Ratio (TTM)	1.10x	2.80x
Debt/Equity (TTM)	1.29x	1.31x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	0.12	0.39
52W Performance	65.1%	57.1%
YTD Performance	33.4%	45.6%
% from 52W High	-9.5%	-12.1%
% from 52W Low	73.1%	60.6%
Efficiency & Yields
Asset Turnover (TTM)	0.51x	0.13x
FCF Yield (TTM)	4.6%	1.8%
Earnings Yield (TTM)	0.9%	2.5%
Dividend Yield (TTM)	2.3%	1.2%
Other
Rule of 40	28.8	32.8
EV/GP/RG	2.37	N/A
Ticker research	View MRK research	View RPRX research